Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110452270A reveals stable catalyst for alpha,beta-unsaturated ketones. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN111018735B enables metal-free cinnamamide production. Reduces purification costs and ensures high purity for pharmaceutical supply chains effectively.
Discover the novel AgNO3-catalyzed synthesis of polycyclic pyridine compounds. This patent offers cost reduction in pharmaceutical intermediate manufacturing with high efficiency.
Patent CN108358916B details solvent-free ball milling for high-purity R-Praziquantel. Reduces cost and waste for reliable pharmaceutical intermediate supply chains.
Patent CN103626759A details a high-yield synthesis of Apixaban intermediate using dichloromethane, offering significant cost reduction and purity improvements for API manufacturing supply chains.
Efficient two-step synthesis for bromodomain inhibitors. High yield, mild conditions, scalable for pharmaceutical intermediates manufacturing.
Patent CN116334022B reveals high-efficiency transaminase mutant for Rivastigmine intermediate. Offers superior yield and purity for scalable pharmaceutical manufacturing.
Advanced synthesis of Vitamin A intermediates using tetrachloroglycoluril. Enhanced yield, reduced waste, and reliable supply chain solutions for global pharmaceutical manufacturers.
Patent CN116655532B offers high-yield route. Reduces toxic reagents. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Patent CN108558715A details high-yield route. Reduces cost and environmental impact for pharmaceutical intermediates manufacturing significantly.
Patent CN105568312A reveals metal-free electrocatalytic synthesis for 2-arylpyrroles. Achieve high purity and cost reduction in fine chemical manufacturing with green technology.
Novel synthesis route for immunomodulator intermediate reduces metal residues. Cost-effective scale-up for pharma supply chains.
Patent CN113801095B reveals a novel two-step method improving yield and purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Efficient one-step synthesis method for pharmaceutical intermediates. Reduces cost and improves supply chain reliability for complex heterocycles significantly.
Novel Pd-free route for WRN inhibitor intermediate ensures high purity and scalable supply chain reliability for global pharma partners.
Novel Pd-catalyzed route offers high beta-selectivity and yield for pharmaceutical intermediates. Enables cost reduction and supply chain reliability for global buyers.
Patent CN106543244A details enzymatic synthesis of galactosyl salidroside. Offers high yield, mild conditions, and cost-effective manufacturing for pharmaceutical supply chains.
Novel one-pot method for azlactone derivatives eliminates phosphorus waste, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN107531649B reveals novel carboxylic acid URAT1 inhibitors. Discover scalable synthesis routes and supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN112981436B reveals a metal-free electrochemical route for thiadiazoles, offering cleaner manufacturing and scalable supply for API intermediates.